Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Copper-67 SAR-bisPSMA updates

SYDNEY, Oct. 16, 2024 /PRNewswire/ -- HIGHLIGHTS Cohort 4 - SECuRE Trial * The third participant of cohort 4 (multi-dose) of the SECuRE trial1 has now completed the Dose Limiting Toxicity (DLT) period after a second dose of 12GBq of67Cu-SAR-bisPSMA, following on from the announcement dated 1...

2024-10-16 21:03 2186

Tanner Health and Healthliant Ventures Partner With Corti to Accelerate Medical Coding, Cutting Workload by 80 Percent

CARROLLTON, Ga., Oct. 16, 2024 /PRNewswire/ -- In a move set to transform healthcare operations acrossGeorgia and Alabama, Tanner Health and Healthliant Ventures have announced a strategic partnership with Corti, the trusted AI platform to healthcare systems worldwide. The collaboration is expect...

2024-10-16 21:00 2283

IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer

HONG KONG, Oct. 16, 2024 /PRNewswire/ -- Akeso Biopharma (9926.HK) (" Akeso", the "Company" ) announced positive results in progression-free survival (PFS) and overall survival (OS) from its Phase 3 clinical study (COMPASSION-16/AK104-303). This study evaluated the efficacy of its independently...

2024-10-16 19:02 1211

TenNor Announces More than 300 Million RMB Financing to Support Development and Commercialization of Late-Stage Assets Including Rifasutenizol for Heliobacter pylori Infections

SUZHOU, China, Oct. 16, 2024 /PRNewswire/ -- TenNor Therapeutics, a clinical stage company dedicated to developing new therapies to address unmet needs in infectious diseases, announced today the initial closing of a Series E financing round for more than300 million RMB. New investor AMR Action F...

2024-10-16 18:00 1596

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

PISCATAWAY, N.J., Oct. 16, 2024 /PRNewswire/ -- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments from capital markets. To strengthen this vital sector, GenScript is bringing together leading sc...

2024-10-16 17:43 985

SONIRE's HIFU Therapy System Designated as Breakthrough Device by FDA

TOKYO, Oct. 16, 2024 /PRNewswire/ -- SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based inTokyo, Japan, announces that its self-developed next-generation HIFU (High-Intensity Focused Ultrasound) therapy system (development code: Suizenji) has been designated as a breakthrough ...

2024-10-16 14:00 1101

Frost & Sullivan grants the 2024 Global Pluripotent stem cell drug R&D Innovation Award to ZEPHYRM BIOTECHNOLOGIES

SHANGHAI, Oct. 16, 2024 /PRNewswire/ -- The 18th The Growth Innovation Leadership (GIL) Council & the 3rd New Investment Conference in 2024 was held in Shanghai from August 28 to 30, 2024. On the evening of August 28, the prestigious 2024 Global and China Awards for Growth, Innovation, and Leaders...

2024-10-16 13:35 1362

Members Health Calls for National Reform to Strengthen Healthcare and Bolster Economic Prosperity and Social Wellbeing

MELBOURNE, Australia, Oct. 16, 2024 /PRNewswire/ -- Members Health is calling for major reforms to boost health care accessibility and affordability and improve transparency of hospitals and doctors acrossAustralia as part of a landmark report released today for the not-for-profit health insuranc...

2024-10-16 06:12 1387

Members Health Calls for National Reform to Strengthen Healthcare and Bolster Economic Prosperity and Social Wellbeing

Cardiex Awarded $525,000 Grand Prize in NIH RADx Tech for Maternal Health Challenge

SYDNEY, Oct. 16, 2024 /PRNewswire/ -- Cardiex, a global health technology company specializing in cardiovascular diagnostics and devices, today announced it has been awarded the$525,000 grand prize in the US National Institutes of Health (NIH) RADx Tech for Maternal Health Challenge. The award re...

2024-10-16 06:00 1971

AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors

HAMILTON, ON, Oct. 16, 2024 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has entered into an agreement with Radiopharm Ventures (RV), a Joint Venture between Radiopharm Theranostics (RAD) and MD And...

2024-10-16 05:00 925

AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors

PharmAust affirms corporate strategy with name change to Neurizon Therapeutics

MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to announce it has officially changed its name from PharmAust L...

2024-10-16 04:14 1243

MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members

* American Heart Association Ventures invests in MDisrupt * Lisa Suennen, Managing Partner of American Heart Association Ventures and longtime healthcare veteran, joins the MDisrupt board * MDisrupt's marketplace will be made available to thousands of the American Heart Association's profe...

2024-10-16 03:00 1356

RLDatix Appoints Dan Michelson as Chief Executive Officer

Michelson succeeds Jeff Surges who transitions into Board Advisor Role CHICAGO, Oct. 16, 2024 /PRNewswire/ -- RLDatix, a leading global provider of connected healthcare operations software and services, announced today the appointment ofDan Michelson as its new Chief Executive Officer and a membe...

2024-10-15 23:28 1126

RLDatix Appoints Dan Michelson as Chief Executive Officer

Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting

SHENZHEN, China, Oct. 15, 2024 /PRNewswire/ -- On October 15, 2024, the list of selected candidates for the oral report of the American Association for the Study of the Liver (AASLD 2024) annual meeting was officially announced online. The abstract of the Phase II clinical study (CGZ203 trial) on...

2024-10-15 22:08 1346

Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne

The Groundbreaking Accure Laser System is now indicated for the long-term treatment of mild to severe inflammatory acne vulgaris BOULDER, Colo., Oct. 15, 2024 /PRNewswire/ -- Accure Acne, Inc.™ ( www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, ...

2024-10-15 21:50 1036

Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne

Operation Smile Featured in "Beyond the Code," a New Branded Series that Explores How AI Is Driving Transformative Change

VIRGINIA BEACH, Va., Oct. 15, 2024 /PRNewswire/ -- Global nonprofit Operation Smile today announced its involvement in Beyond the Code, a new branded series presented by Partnership onAI (PAI) and produced by BBC StoryWorks Commercial Productions. The first of its kind, this online series – which...

2024-10-15 21:00 984

Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis'

- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collaborates leveraging Neurophet's medical image analysis technology and AriBio's clinical trial data analysis expertise SEOUL, South Korea, Oct. 1...

2024-10-15 21:00 1208

Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis'

Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation

MILAN, Oct. 15, 2024 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, unveiled its Hyatrue® Sterile Sodium Hyaluronate (HA) and showcased its BloomseaN™ Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) at CPHI Milan. Known to be at "the...

2024-10-15 21:00 749

Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation

Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection

HONG KONG, Oct. 15, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced thatTencent has made a strategicUS$30 million investment in Insighta, a Hong Kong-based early cancer detection company. This investment values Insighta atUS$200 mill...

2024-10-15 20:50 3532

Gan & Lee Pharmaceuticals' Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies

* After 24 weeks of treatment in patients with Type 2 diabetes, the bi-weekly GLP-1 receptor agonist GZR18 injection showed superior efficacy in lowering HbA1c and body weight compared to semaglutide (Ozempic®). * After 16 weeks of treatment in patients with Type 2 diabetes, the once-weekly i...

2024-10-15 19:36 1177

Gan & Lee Pharmaceuticals' Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies

1 ... 13 14 151617 18 19 ... 610